Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SCAND2 |
| Upstream (Parents) |
|---|
| (<<) TRIM29 → SCAND2 |
| (<<) NFE2 → SCAND2 |
| (<<) BRD8 → SCAND2 |
| (<<) FOXO3 → SCAND2 |
| (<<) HOXA5 → SCAND2 |
| (<<) HOXA4 → SCAND2 |
| (<<) FUBP1 → SCAND2 |
| (<<) RORC → SCAND2 |
| (<<) RARA → SCAND2 |
| (<<) HNF1A → SCAND2 |
| (<<) VSX1 → SCAND2 |
| (<<) KLF1 → SCAND2 |
| (<<) MSL3 → SCAND2 |
| (<<) FOXN1 → SCAND2 |
| (<<) HMBOX1 → SCAND2 |
| Downstream (Children) |
|---|
| SCAND2 → MYT1L (>>) |
| SCAND2 → FOXL2 (>>) |
| SCAND2 → POU4F3 (>>) |
| SCAND2 → ELK1 (>>) |
| SCAND2 → TP63 (>>) |
| SCAND2 → EN1 (>>) |
| SCAND2 → PGR (>>) |
| SCAND2 → ZFP36L1 (>>) |
| SCAND2 → RERE (>>) |
| SCAND2 → RORB (>>) |
| SCAND2 → GBX2 (>>) |
| SCAND2 → ZNF155 (>>) |
| SCAND2 → ZNF444 (>>) |
| SCAND2 → FOXE3 (>>) |
| SCAND2 → SRF (>>) |
